14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 TTNP stock ended at $6.88. This is 2.69% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.03% from a day low at $6.81 to a day high of $6.88.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Titan Pharmaceuticals prices

Date Open High Low Close Volume
Nov 02, 2023 $0.435 $0.450 $0.420 $0.430 2 979
Nov 01, 2023 $0.376 $0.470 $0.360 $0.430 20 424
Oct 31, 2023 $0.400 $0.450 $0.376 $0.401 28 342
Oct 30, 2023 $0.420 $0.450 $0.410 $0.434 19 650
Oct 27, 2023 $0.430 $0.500 $0.410 $0.421 26 448
Oct 26, 2023 $0.440 $0.490 $0.410 $0.436 24 310
Oct 25, 2023 $0.353 $0.500 $0.349 $0.422 211 101
Oct 24, 2023 $0.340 $0.570 $0.320 $0.370 738 526
Oct 23, 2023 $0.370 $0.388 $0.313 $0.340 116 021
Oct 20, 2023 $0.449 $0.455 $0.360 $0.381 47 984
Oct 19, 2023 $0.499 $0.500 $0.420 $0.420 12 152
Oct 18, 2023 $0.460 $0.486 $0.450 $0.475 15 591
Oct 17, 2023 $0.400 $0.510 $0.400 $0.465 38 427
Oct 16, 2023 $0.478 $0.500 $0.442 $0.442 22 091
Oct 13, 2023 $0.440 $0.492 $0.433 $0.460 21 236
Oct 12, 2023 $0.450 $0.470 $0.440 $0.440 2 105
Oct 11, 2023 $0.437 $0.460 $0.430 $0.440 10 643
Oct 10, 2023 $0.430 $0.460 $0.383 $0.450 40 913
Oct 09, 2023 $0.462 $0.469 $0.430 $0.430 10 754
Oct 06, 2023 $0.482 $0.482 $0.430 $0.430 5 414
Oct 05, 2023 $0.465 $0.492 $0.450 $0.450 10 252
Oct 04, 2023 $0.474 $0.466 $0.440 $0.466 11 053
Oct 03, 2023 $0.440 $0.473 $0.430 $0.455 25 667
Oct 02, 2023 $0.464 $0.473 $0.440 $0.458 22 718
Sep 29, 2023 $0.453 $0.492 $0.457 $0.474 2 273
Click to get the best stock tips daily for free!

About Titan Pharmaceuticals

Titan Pharmaceuticals Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination... TTNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT